Breast cancer index customer service
WebDec 17, 2024 · breast cancer oncology anti-estrogen therapy endocrine therapy personalized medicine genomic medicine Contact Data Lisa Whitmyer Biotheranostics, …
Breast cancer index customer service
Did you know?
WebMay 5, 2024 · The American Society of Clinical Oncology has published an update which expands the utility of Breast Cancer Index (BCI) within its Clinical Practice Guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”Specifically, ASCO now recognizes BCI as the only genomic test to help guide … WebRead the Full Publication. Breast Cancer Index predicts extended endocrine benefit to individualize selection of HR+ early stage breast cancer patients for 10 years of endocrine therapy. References: 1. Noordhoek et al. Clin Cancer Res. Oct 2024. DOI: 10.1158/1078-0432.CCR-20-2737.
WebThe American Cancer Society has many programs and services to help you understand cancer, get practical help like rides to treatment or a place to stay, and find emotional support. We can also connect you to valuable resources in your community. Enter your postal code below or call us at 1-800-227-2345 to find help in your area. WebFor Breast Cancer Index Intended Use and Limitations, visit the full site. Biotheranostics, Inc., A Hologic Company 6333 Sequence Dr., San Diego, CA 92121 1 (877) 886-6739. …
WebJan 1, 2024 · Purpose: Individualized selection of patients with early-stage hormone receptor-positive (HR +) breast cancer for extended endocrine therapy (EET) is required to balance modest gains in outcome with toxicities of prolonged use.This study examined the Breast Cancer Index [BCI; HOXB13/IL17BR ratio (H/I)] as a predictive biomarker of … WebCall 713-745-9998 or 1-844-331-9998 (toll-free). Payments made by cash, personal pre-printed checks, cashier checks and wire transfers can be arranged with a financial …
WebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive …
WebDec 6, 2024 · Ductal carcinoma is the most common type of breast cancer. This type of cancer forms in the lining of a milk duct within your breast. The ducts carry breast milk … lua bathroomWebBreast Cancer Index Intended Uses and LimitationsThe Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test is indicated for use in women diagnosed with hormone receptor-positive (HR+), lymph node-negative (LN-) or lymph node-positive … Order The Test - Breast Cancer Index Nearly 95% of Women Do Not Benefit from Anti-Estrogen Therapy After 5 Years 1 … While most women with early-stage HR+ breast cancer are prescribed anti … Breast Cancer Index may be right for you if you are looking for more information to … NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) and the … How Do I Get The Test - Breast Cancer Index Order BCI - Breast Cancer Index Health Economics Study - Breast Cancer Index About Breast Cancer Index TM. Breast Cancer Index ® is a molecular, gene … pact allianceWebAt our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, … lua apassionato cd playerhttp://www.biotheranostics.com/ pact act vote roll callWebJan 4, 2024 · Breast Cancer Index (or BCI) is a new test to help determine if you are likely to benefit from an additional five years of anti-estrogen medication. BCI can also provide … pact algorithmWebThe Breast Cancer Index test helps determine if 5 or 10 years of endocrine therapy is likely to benefit your early-stage, HR+ breast cancer patients. Order the test and help her … lua access_by_lua_fileWebMay 17, 2024 · According to the American Cancer Society, about 1 in 8 females in the United States will develop breast cancer at some point in their lifetime. One of the risk factors for breast cancer is ... pact act veterans radiation